tricalcium phosphate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howard, CB; Huang, L; Li, B; Mahler, SM; Tang, J; Thurecht, KJ; Wu, Y; Xu, ZP | 1 |
| Cheng, Y; Ji, Q; Liu, B; Liu, D; Liu, M; Yang, Q; Yang, Z; Zhang, B; Zhou, S | 1 |
| Howard, CB; Huang, L; Mahler, SM; Tang, J; Thurecht, KJ; Xu, ZP | 1 |
| Kennell, C; Lee, JY; Leung, YK; Tarapore, P; Zhou, Z | 1 |
4 other study(ies) available for tricalcium phosphate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy.
Topics: Animals; Calcium Phosphates; Cell Line, Tumor; Coloring Agents; Drug Carriers; Drug Delivery Systems; Female; Genetic Therapy; Humans; Hyperthermia, Induced; Indocyanine Green; Lipids; Mice; Mice, Inbred BALB C; Nanoparticles; RNAi Therapeutics; Triple Negative Breast Neoplasms | 2019 |
Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
Topics: Bone Marrow Diseases; Bone Neoplasms; Calcium Phosphates; Cell Line, Tumor; Docetaxel; Humans; Immunosuppression Therapy; Micelles; Osteolysis; Triple Negative Breast Neoplasms; Tumor Microenvironment; Zoledronic Acid | 2023 |
Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.
Topics: Animals; Calcium Phosphates; Cell Line, Tumor; Drug Delivery Systems; Humans; Ligands; Lipids; Mice; Mice, Nude; Nanoparticles; RNA, Small Interfering; Single-Chain Antibodies; Triple Negative Breast Neoplasms | 2018 |
Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors.
Topics: Antineoplastic Agents, Phytogenic; Calcium Phosphates; Cell Line, Tumor; Humans; MicroRNAs; Nanoparticles; Paclitaxel; Polymers; Triple Negative Breast Neoplasms | 2017 |